This study will test a new vaccine to protect against Ebola virus
This study will test a new vaccine for Respiratory Syncytial Virus (RSV) in young children – a major cause of respiratory illness (infection of the airways).
This study measures mother’s antibody protection passed to their newborn. It does not involve any drugs or vaccines.
Time: 10:30am – 11:30am
Location: CCfV conference room & on-line webinar
Date: December 19, 2014
Vaccines are complex biologics made from living organisms. Vaccines to prevent disease work. Read more…
The Clinical Trials Research Center (CTRC), now a division of the Canadian Center for Vaccinology, was originally established in 1992. Read more…